AGEN vs. ETHSX

Last updated Apr 2, 2026

Compare and contrast key facts about Agenus Inc. (AGEN) and Eaton Vance Worldwide Health Sciences Fund (ETHSX).

ETHSX is managed by Eaton Vance. It was launched on Jul 25, 1985.

Performance

AGEN vs. ETHSX - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Agenus Inc. (AGEN) and Eaton Vance Worldwide Health Sciences Fund (ETHSX). The values are adjusted to include any dividend payments, if applicable.

AGEN vs. ETHSX - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023	2022	2021	2020	2019	2018	2017
AGEN Agenus Inc.	8.28%	14.60%	-83.45%	-64.85%	-25.47%	1.26%	-21.87%	71.01%	-26.99%	-20.87%
ETHSX Eaton Vance Worldwide Health Sciences Fund	-5.95%	10.23%	3.48%	5.67%	-9.41%	22.02%	13.04%	25.99%	5.87%	16.24%

Returns By Period

In the year-to-date period, AGEN achieves a 8.28% return, which is significantly higher than ETHSX's -5.95% return. Over the past 10 years, AGEN has underperformed ETHSX with an annualized return of -27.35%, while ETHSX has yielded a comparatively higher 7.59% annualized return.

AGEN

• 1D: 1.80%
• 1M: 1.80%
• YTD: 8.28%
• 6M: -12.82%
• 1Y: 112.50%
• 3Y*: -51.52%
• 5Y*: -42.96%
• 10Y*: -27.35%

ETHSX

• 1D: 2.21%
• 1M: -6.44%
• YTD: -5.95%
• 6M: 1.02%
• 1Y: 1.32%
• 3Y*: 4.41%
• 5Y*: 4.55%
• 10Y*: 7.59%

*Multi-year figures are annualized to reflect compound growth (CAGR)

Return for Risk

AGEN vs. ETHSX — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

AGEN

AGEN Risk / Return Rank: 75
AGEN Sharpe Ratio Rank: 76
AGEN Sortino Ratio Rank: 81
AGEN Omega Ratio Rank: 75
AGEN Calmar Ratio Rank: 77
AGEN Martin Ratio Rank: 68

ETHSX

ETHSX Risk / Return Rank: 5
ETHSX Sharpe Ratio Rank: 4
ETHSX Sortino Ratio Rank: 4
ETHSX Omega Ratio Rank: 4
ETHSX Calmar Ratio Rank: 5
ETHSX Martin Ratio Rank: 5

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

AGEN vs. ETHSX - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Agenus Inc. (AGEN) and Eaton Vance Worldwide Health Sciences Fund (ETHSX). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

	AGEN	ETHSX	Difference
Sharpe ratio Return per unit of total volatility	1.11	0.01	+1.10
Sortino ratio Return per unit of downside risk	2.20	0.14	+2.06
Omega ratio Gain probability vs. loss probability	1.25	1.02	+0.24
Calmar ratio Return relative to maximum drawdown	2.07	0.03	+2.04
Martin ratio Return relative to average drawdown	3.31	0.07	+3.23
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month.

AGEN vs. ETHSX - Sharpe Ratio Comparison

The current AGEN Sharpe Ratio is 1.11, which is higher than the ETHSX Sharpe Ratio of 0.01. The chart below compares the historical Sharpe Ratios of AGEN and ETHSX, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.

Sharpe Ratios by Period

	AGEN	ETHSX	Difference
Sharpe Ratio (1Y) Calculated over the trailing 1-year period	1.11	0.01	+1.10
Sharpe Ratio (5Y) Calculated over the trailing 5-year period	-0.45	0.31	-0.76
Sharpe Ratio (10Y) Calculated over the trailing 10-year period	-0.33	0.47	-0.80
Sharpe Ratio (All Time) Calculated using the full available price history	-0.29	0.03	-0.32

Correlation

The correlation between AGEN and ETHSX is 0.36, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.

Dividends

AGEN vs. ETHSX - Dividend Comparison

AGEN has not paid dividends to shareholders, while ETHSX's dividend yield for the trailing twelve months is around 7.83%.

	TTM	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015
AGEN Agenus Inc.	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
ETHSX Eaton Vance Worldwide Health Sciences Fund	7.83%	7.36%	4.81%	2.48%	4.43%	8.25%	7.33%	5.39%	5.51%	2.82%	12.75%	9.70%

Drawdowns

AGEN vs. ETHSX - Drawdown Comparison

The maximum AGEN drawdown since its inception was -99.98%, which is greater than ETHSX's maximum drawdown of -90.06%. Use the drawdown chart below to compare losses from any high point for AGEN and ETHSX.

Drawdown Indicators

	AGEN	ETHSX	Difference
Max Drawdown Largest peak-to-trough decline	-99.98%	-90.06%	-9.92%
Max Drawdown (1Y) Largest decline over 1 year	-60.76%	-11.26%	-49.50%
Max Drawdown (5Y) Largest decline over 5 years	-98.84%	-19.58%	-79.26%
Max Drawdown (10Y) Largest decline over 10 years	-98.96%	-27.43%	-71.53%
Current Drawdown Current decline from peak	-99.95%	-10.46%	-89.49%
Average Drawdown Average peak-to-trough decline	-93.62%	-53.13%	-40.49%
Ulcer Index Depth and duration of drawdowns from previous peaks	38.07%	4.52%	+33.55%

Volatility

AGEN vs. ETHSX - Volatility Comparison

Agenus Inc. (AGEN) has a higher volatility of 29.14% compared to Eaton Vance Worldwide Health Sciences Fund (ETHSX) at 5.09%. This indicates that AGEN's price experiences larger fluctuations and is considered to be riskier than ETHSX based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	AGEN	ETHSX	Difference
Volatility (1M) Calculated over the trailing 1-month period	29.14%	5.09%	+24.05%
Volatility (6M) Calculated over the trailing 6-month period	53.86%	10.50%	+43.36%
Volatility (1Y) Calculated over the trailing 1-year period	102.42%	17.73%	+84.69%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	95.35%	14.74%	+80.61%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	82.80%	16.25%	+66.55%